Your browser doesn't support javascript.
loading
Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia.
Owen, Carolyn; Eisinga, Sarah; Banerji, Versha; Johnson, Nathalie; Gerrie, Alina S; Aw, Andrew; Chen, Christine; Robinson, Sue.
Afiliação
  • Owen C; Division of Hematology and Hematological Malignancies, Foothills Medical Centre, Calgary AB T2N 4N2, Canada. Electronic address: carolyn.owen@ahs.ca.
  • Eisinga S; Lymphoma Canada, Mississauga, ON, L5N 2W5, Canada.
  • Banerji V; Department of Hematology and Medical Oncology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
  • Johnson N; Department of Medicine, Jewish General Hospital, Montreal QC H3T 1E2, Canada.
  • Gerrie AS; Division of Medical Oncology, Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Aw A; Division of Hematology, The Ottawa Hospital, Ottawa, Ontario K1Y 4E9, Canada.
  • Chen C; Department of Medical Oncology, University of Toronto, and Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
  • Robinson S; Division of Hematology, Dalhousie University, and GEII Health Sciences Centre, Halifax NS B3H 2Y9, Canada.
Leuk Res ; 133: 107372, 2023 10.
Article em En | MEDLINE | ID: mdl-37633157
ABSTRACT
Following the recent publication of Canadian evidence-based guidelines for frontline treatment of chronic lymphocytic leukemia (CLL), the same group of clinicians developed guidelines for CLL in the relapsed/refractory (R/R) setting. The treatment of R/R CLL has changed significantly in the past few years, with many novel therapeutics available to hematologists across the country. These guidelines aim to standardize the management of CLL in the relapsed/refractory setting, using the best evidence currently available.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Guideline Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Leuk Res Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Guideline Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Leuk Res Ano de publicação: 2023 Tipo de documento: Article